PI.NASDAQImpinj INC

Form 4: Sylebra Capital Reduces Impinj Stake

Sentiment:

Insider Transaction Report


Sylebra Capital LLC and related entities reported sales of Impinj Inc. common stock totaling 87,138 shares in December 2025.

Summary

  • Sylebra Capital LLC, a significant shareholder and entity associated with Impinj Inc. director Daniel Patrick Gibson, reported sales of Impinj Inc. common stock.
  • A total of 87,138 shares were disposed of across three separate transactions on December 8, 9, and 10, 2025.
  • The sales were executed at prices ranging from $155.4929 to $160.7197 per share.
  • Following these transactions, Sylebra Capital LLC and its related entities indirectly beneficially own 1,412,699 shares of Impinj Inc. common stock.
  • The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The filing reports routine insider sales by a significant shareholder and director, conducted under a Rule 10b5-1 plan. While sales reduce insider ownership, the pre-arranged nature of the plan suggests it may not be directly tied to new negative information about the company.

Positives

  • NA

Negatives

  • Sylebra Capital LLC and related entities reduced their indirect beneficial ownership in Impinj Inc. by 87,138 shares through open market sales.

Risks

  • NA

Future Outlook

NA

Industry Context

NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorNADaniel Patrick GibsonNANA

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
NANANANA

Related Party Transactions

  • Sales of Impinj Inc. common stock by Sylebra Capital LLC and related entities, where Daniel Patrick Gibson, a director of Impinj Inc., is associated with Sylebra Capital entities.

Stakeholder Impact

  • Shareholders: The reduction in a significant institutional holding by entities associated with a director could lead to negative market sentiment, although the execution under a Rule 10b5-1 plan may mitigate some concerns.

Key Dates

DateDescription
12/08/2025Sale of 2,494 shares of Common Stock by Sylebra Capital LLC at $160.7197 per share.
12/09/2025Sale of 40 shares of Common Stock by Sylebra Capital LLC at $160.0125 per share.
12/10/2025Sale of 84,604 shares of Common Stock by Sylebra Capital LLC at $155.4929 per share.

Recommendation

hold

The filing reports insider sales by a significant shareholder and director, executed under a Rule 10b5-1 plan. While insider selling can sometimes signal a lack of confidence, the pre-scheduled nature of these transactions often indicates personal financial planning rather than a reaction to new material information. Without additional context on the company's performance, valuation, or broader market trends, a 'hold' recommendation is appropriate, advising investors to maintain their current position while monitoring future developments.

Keywords

Impinj, PI, Sylebra Capital, Insider Transaction, Form 4, Beneficial Ownership, Stock Sale, Director Transaction, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.